RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Peak Pharmaceuticals Stock

Peak Pharmaceuticals P/S 2024

Peak Pharmaceuticals P/S

0

Ticker

PKPH

ISIN

US70469W1062

WKN

A14NHS

As of Oct 9, 2024, Peak Pharmaceuticals's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.

The Peak Pharmaceuticals P/S history

Peak Pharmaceuticals Aktienanalyse

What does Peak Pharmaceuticals do?

Peak Pharmaceuticals Inc. is a company specializing in the development and marketing of pharmaceutical products. The company was founded in 2007 and is headquartered in Denver, Colorado. The company's history began with the vision of a group of experts in the pharmaceutical industry who aimed to develop innovative products that could improve people's lives. With their years of experience and expertise in drug research and development, they offered a promising perspective for the future. The company's business model is based on the creation of valuable active substances that cover a wide range of therapeutic applications. Peak Pharmaceuticals' products are designed to meet the complex needs of patients facing serious conditions such as cancer, pain, and neurological disorders. The company focuses on creating drugs that can increase therapy effectiveness and improve patients' quality of life. Peak Pharmaceuticals Inc. has developed several divisions in recent years to expand its presence in various markets. One significant area is the development of products for the cardiovascular field, focusing on the treatment of heart diseases. Another important area is the creation of drugs for the treatment of cancer, specifically tailored to the needs of patients with different types of cancer. Peak Pharmaceuticals also has a division for pain management, with products that can be used to relieve acute and chronic pain. The company has developed a wide range of pharmaceutical products based on innovative technologies such as nanotechnology, plant extracts, and other natural active substances. Peak Pharmaceuticals' products are the result of years of research and development, and they have been tested in clinical trials to ensure their effectiveness and safety. An example of a product from Peak Pharmaceuticals is PNTV, a cannabinoid-based pain medication. This medication was specifically developed for the treatment of pain in fibromyalgia and neuropathy and has been tested in clinical trials. Another example is B-link, a cancer medication manufactured using nanotechnology and can be used to treat various types of cancer. Overall, Peak Pharmaceuticals Inc. has established itself as a leading company in the pharmaceutical industry. The company strives to create innovative products that meet the medical needs of consumers and are significant to the healthcare industry. With a combination of passion, knowledge, and dedication, Peak Pharmaceuticals has made significant progress in recent times and looks forward to a promising future. Peak Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Peak Pharmaceuticals's P/S Ratio

Peak Pharmaceuticals's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Peak Pharmaceuticals's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Peak Pharmaceuticals's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Peak Pharmaceuticals’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Peak Pharmaceuticals stock

What is the price-to-earnings ratio of Peak Pharmaceuticals?

The price-earnings ratio of Peak Pharmaceuticals is currently 0.

How has the price-earnings ratio of Peak Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Peak Pharmaceuticals has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Peak Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Peak Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Peak Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Peak Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Peak Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Peak Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Peak Pharmaceuticals?

Some factors that influence the price-earnings ratio of Peak Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Peak Pharmaceuticals pay?

Over the past 12 months, Peak Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Peak Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Peak Pharmaceuticals?

The current dividend yield of Peak Pharmaceuticals is .

When does Peak Pharmaceuticals pay dividends?

Peak Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Peak Pharmaceuticals?

Peak Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Peak Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Peak Pharmaceuticals located?

Peak Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Peak Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Peak Pharmaceuticals from 10/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/9/2024.

When did Peak Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/9/2024.

What was the dividend of Peak Pharmaceuticals in the year 2023?

In the year 2023, Peak Pharmaceuticals distributed 0 USD as dividends.

In which currency does Peak Pharmaceuticals pay out the dividend?

The dividends of Peak Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Peak Pharmaceuticals

Our stock analysis for Peak Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Peak Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.